Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENTRACK GROUP LIMITED Director's Dealing 2025

Dec 11, 2025

65024_rns_2025-12-11_00066651-70ba-4411-9790-391659287834.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [106 x 29] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

ToNZX Limited; and
Name of listed issuer: Gentrack GroupLimited(GTK)
Date this disclosure made: 12-Dec-25
Date of last disclosure: 12-Dec-24
Director or senior managergiving disclosure
Full name(s): John Edward Frederick Priggen
Name of listed issuer: Gentrack GroupLimited(GTK)
Name of related body corporate (if applicable): Not applicable
Position held in listed issuer: Chief Financial Officer
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary Shares in Gentrack Group
Limited(NZX:GTK)
Nature of the affected relevant interest(s):
Receipt of 470,453 ordinary shares
upon vesting of performance rights
under the Gentrack Senior
Management LTI Scheme and
October 2022 LTI Award.
Class of affected quoted financial products: Ordinary Shares in Gentrack Group
Limited(NZX:GTK)
Nature of the affected relevant interest(s): Receipt of 470,453 ordinary shares
upon vesting of performance rights
under the Gentrack Senior
Management LTI Scheme and
October 2022 LTI Award.
For that relevant interest-
Number held in class before acquisition or disposal: 180,571
Number held in class after acquisition or disposal: 651,024
Current registered holder(s): Not applicable as a new issue
Registered holder(s) once transfers are registered: John Edward Frederick Priggen
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Not applicable
Class of underlyingfinancialproducts:
Not applicable
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financialproducts(if any):
Not applicable
A statement as to whether the derivative is cash settled orphysicallysettled:
Not applicable
Not applicable
Not applicable
The notional value of the derivative (if any) or the notional amount of underlying
financialproducts(if any):
Not applicable
A statement as to whether the derivative is cash settled orphysicallysettled: Not applicable
Maturitydate of the derivative(if any): Not applicable
Expirydate of the derivative(if any): Not applicable
Theprice specified in the terms of the derivative(if any): Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Parties to the derivative: Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 2

Details of transactions requiring disclosure-

Date of transaction: 10-Dec-25
Nature of transaction: Issue of new ordinary shares in
Gentrack Group Limited upon vesting
of performance rights under
Gentrack Senior Management LTI
Scheme and October 2022 LTI
Award.
Name of anyotherpartyorparties to the transaction(if known): Gentrack GroupLimited as issuer
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value,describe the consideration:
NIL
Number of financialproducts to which the transaction related: 470,453
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of duringa closedperiod: No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed duringthe closedperiod:
Not applicable
Date of theprior written clearance(if any): Not applicable
Summary of other relevant interests after acquisition or disposal:
Class ofquoted financialproducts:
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Not applicable
Not applicable
Not applicable
Not applicable
Type of derivative: Not applicable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled: Not applicable
Maturity date of the derivative (if any): Not applicable
Expiry date of the derivative (if any): Not applicable
The price's specified terms (if any): Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlyingfinancialproducts:
Not applicable
For that derivative relevant interest,-
Parties to the derivative: Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorisedperson:
Signature of person authorised to sign on behalf of director or officer:
Date of signature: 12-Dec-25
Name and title of authorisedperson: Anna Ellis, CompanySecretary